Correction: Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings

R Michael Grounds¹ and Charles Bolan²

¹Adult Intensive Care Unit, St George's Hospital, London, UK

²COL (retired) US Army Medical Corps, Deputy Chief, Blood Services Section, Department of Transfusion Medicine, Clinical Centre, National Institutes of Health, Bethesda, Maryland, USA

author email corresponding author email

Critical Care 2005, 9:560doi:10.1186/cc3926

Published:

4 November 2005

Correction

Following the publication of the above article [1], we noticed that the Competing interests section was incorrect and should read as follows:

RMG has worked as a consultant for Novo Nordisk and lectured on behalf of Novo Nordisk about NovoSeven.

References

Grounds RM, Bolan C: Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.
Crit Care 2005, 9(Suppl 5):S29-S36. PubMed Abstract | BioMed Central Full Text

Correction: Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings

Correction

References

Have something to say? Post a comment on this article!